3 Stocks Under $10 You Need to Watch

A low per-share price doesn’t necessarily make a stock “cheap.” Much can depend on the number of outstanding shares and other factors. 

However, with stocks under $10, there is often more room to grow and room for larger returns.

The problem? There are plenty of stocks under $10, but many of them aren’t worth your time.

However, there are absolutely gems if you know where to look.

That’s where the Zen Ratings system comes in. This review of 115 factors proven to drive stock growth can help you sift through the many options and find the highest-quality contenders.

Recently, we developed a new way to leverage our ratings system with Zen Strategies — a collection of portfolios with different themes to suit different investors. The “Under $10 Stocks” portfolio is one of our most popular offerings so far. 

Here’s a sampling of the high-caliber under-$10 stocks with solid fundamentals you might find in the portfolio: 

A note from our sponsors...
New Way of Trading Has Gone Viral  

Imagine foreseeing a 30% stock jump - to the day - weeks before it happens. We've developed a way to predict the biggest stock jumps this spring, to the day, with 83% backtested accuracy. In 2024 alone, it would've pointed to gains of 250% in 38 days on (TTWO)... 101% in 10 days on (WSM)... 353% in 48 days on (AON) and more in studies.   

Click here for instant access to our #1 new stock pick, free of charge.

1. Infusystem Holdings (NYSEMKT: INFU)

Infusion pumps might seem like a niche business (and it is), but it doesn’t mean it is a bad business or that INFU isn’t a stock worth taking a closer look at. In fact, the fact that it doesn’t operate across the country yet only highlights room for growth.

While the Momentum Component Grade isn’t strong, consider the investor sentiment behind it or its potential for growth in the years to come. And while it does not have as much coverage as most other stocks, the coverage that is available from analysts provides a rather high price target, ranging from $13 in the past to a more recent $12 (nearly double INFU’s current price).

2. Puma Biotechnology (NASDAQ: PBYI)

Focusing primarily on cancer care in the United States and beyond, PBYI is a biopharmaceutical company with potentially promising drug candidates, some of which have already completed initial clinical testing. Effective cancer therapies and treatments reaching the commercial stage would have the potential to launch PBYI to new heights.

It is regularly considered undervalued, and it has a solid financial foundation, as evidenced by its Financials Component Grade of A. While the share price has declined by 10.31% over the past year, and it had reached much greater heights years ago, this is not indicative of the potential PBYI has for investors who are willing to wait or find promise in the company, provided they are comfortable taking on some risk in the process.

A note from our sponsors...
How to Become Your Own Bank (And Earn 30-400% Annually)  

A former Wall Street insider with a CFA Charter is showing crypto investors how to "become their own bank". This select group is using the same liquidity strategy BlackRock uses to dominate traditional markets... except in crypto where returns are exponentially higher. This allows them to generate income regardless of market direction. Regular investors are already earning up to triple-digit annual returns.  

Click here for the free training to learn how you can earn an extra 30-400% on your digital assets.

3. Udemy (NASDAQ: UDMY)

Udemy provides access to tens of thousands of courses to customers on both the enterprise and individual levels in dozens of languages, having a global reach and an expanding model. Despite that, as of this writing, the share price is only $7.53.

For its Component Grades, it scores a B for Growth, Sentiment, and Financials. Investors see room for growth in UDMY, and the fundamentals support this view. It also helps that earnings and revenues reports last week surpassed estimates, leading to a share price gain over the last week.

Want more information on all of these stocks and more, and want to track them more easily? Then WallStreetZen Premium is for you. With it, you’ll get all the fundamental information you need, an unlimited watchlist, and more. It’s perfect for keeping a close eye on stocks with strong potential that could grow in the blink of an eye.

Looking for a more guided approach on top of good information? Check out Zen Strategies — your fast-forward button to locating the highest-potential stocks across a variety of themes in minutes per month. 

What to Do Next?

• 9 Special Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.